YUHSpace: Browsing DSpace

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)BioMedical Science Institute (의생명과학부)1. Journal Papers

Browsing "1. Journal Papers" by Author : 4283

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

or enter first few letters:

Sort by:
In order:
Results/Page
Authors/Record:

Showing results 20 to 38 of 38

This table browses all dspace content
Issue Date	Title	Journal Title
2016	Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative	ONCOTARGET
2019	Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer	Annals of Oncology
2019	Identification of TRE-130 as Reversible Inhibitor of Pan-EGFR Mutants while Sparing EGFR Wild-Type Activity	BULLETIN OF THE KOREAN CHEMICAL SOCIETY
2021	Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma	CLINICAL CANCER RESEARCH
2022	Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2020	Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck	BRITISH JOURNAL OF CANCER
2019	Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma	SCIENTIFIC REPORTS
2016	PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients	SCIENTIFIC REPORTS
2020	Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer	SCIENTIFIC REPORTS
2015	Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck	CLINICAL CANCER RESEARCH
2015	Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma	ONCOTARGET
2023	Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies	CANCERS
2019	Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models	LUNG CANCER
2017	Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma	CANCER RESEARCH AND TREATMENT
2020	Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer	CLINICAL CANCER RESEARCH
2019	Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer	EMBO MOLECULAR MEDICINE
2021	The promise of bispecific antibodies: Clinical applications and challenges	CANCER TREATMENT REVIEWS
2019	YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer	CLINICAL CANCER RESEARCH
2022	YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment	FRONTIERS IN CHEMISTRY

1

License

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links